<style face="normal" font="default" size="100%">Overcoming the lack of oral availability of cyclic hexapeptides: design of a selective and orally available ligand for the integrin alpha v beta 3</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Overcoming the lack of oral availability of cyclic hexapeptides: design of a selective and orally available ligand for the integrin alpha v beta 3</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Selective targeting of integrin alpha v beta 8 by a highly active cyclic peptide</style>

Drupal-Biblio

17

<style face="normal" font="default" size="100%">Novel cilengitide-based cyclic RGD peptides as alpha nu beta(3) integrin inhibitors</style>